Doxycycline hydrochloride orally disintegrating tablet for beasts and birds, and preparation method thereof

A technology for doxycycline hydrochloride and oral disintegrating tablets, which is applied in the directions of tetracycline active ingredients, pharmaceutical formulations, pill delivery, etc., to achieve the effects of low side effects, less intestinal residues, and simple production equipment

Inactive Publication Date: 2017-07-07
TIANJIN HENGSHENG GAOKE BIOLOGICAL TECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Doxycycline hydrochloride orally disintegrating tablets have not been produced at home and abroad, and there is no development of this product. Therefore, there is an urgent need to develop one and a series of drugs that are convenient to administer, do not need to be given water, absorb quickly, and are bioavailable. Veterinary drug products with high concentration, taking method, good taste, less intestinal residues, low side effects, avoiding the first-pass effect of the liver, or requiring only a small amount of water and no need to chew, so as to make up for the gap in the domestic veterinary drug market in terms of dosage forms, and to treat livestock and poultry Emergency-specific drug for serious infections opens new avenue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Doxycycline hydrochloride orally disintegrating tablet for beasts and birds, and preparation method thereof
  • Doxycycline hydrochloride orally disintegrating tablet for beasts and birds, and preparation method thereof
  • Doxycycline hydrochloride orally disintegrating tablet for beasts and birds, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A doxycycline hydrochloride orally disintegrating tablet for livestock and poultry, its constituent components and parts by weight are respectively (according to the ratio of raw and auxiliary materials per 1000 doxycycline hydrochloride orally disintegrating tablets, the same as in the following examples) :

[0025]

[0026] The raw material drug of doxycycline hydrochloride orally disintegrating tablet involved in the present invention is doxycycline hydrochloride, and its chemical name is: 6-methyl-4-(dimethylamino)-3,5,10,12, 12a, -Pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-Octahydro-2-tetracenecarboxamide hydrochloride hemiethanol hemihydrate.

[0027] A preparation method of doxycycline hydrochloride orally disintegrating tablets for livestock and poultry, comprising the steps of:

[0028] (1) Pass doxycycline hydrochloride, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, and lactose through an 80-mesh sieve for later use;

[0029] (2) ...

Embodiment 2

[0036] A doxycycline hydrochloride orally disintegrating tablet for livestock and poultry, its constituent components and parts by weight are respectively:

[0037]

[0038] The steps of the preparation method of this embodiment are the same as those in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a doxycycline hydrochloride orally disintegrating tablet for livestock and poultry and a preparation method thereof. 150 parts, 25-60 parts of low-substituted hydroxypropyl cellulose, 50-120 parts of lactose, 30-100 parts of aspartame, 10-30 parts of fresh milk king essence, 0.3-1 part of sodium saccharin, magnesium stearate 1-3 servings. The present invention has simple production equipment, easy operation, small weight difference, and low cost, breaks the routine of producing orally disintegrating tablets only by freeze-drying process, and opens up the domestic production of orally disintegrating tablets by adopting general powder granule compression technology, It is a major breakthrough in domestic oral preparation processing technology, and it has opened up a new way for the domestic veterinary drug market to treat emergencies.

Description

technical field [0001] The invention belongs to the technical field of medicine preparation, in particular to a doxycycline hydrochloride orally disintegrating tablet for livestock and poultry and a preparation method thereof. Background technique [0002] With the rapid development of my country's livestock and poultry breeding industry and the continuous development of veterinary drug research, the application of antibiotics in the treatment of various diseases and infections of livestock and poultry has become common, which is of great importance to the improvement of the survival rate and health level of livestock and poultry as well as the effective control and treatment of diseases. played a positive role. Doxycycline hydrochloride is a tetracycline antibiotic, its antibacterial spectrum is similar to other tetracyclines, and its antibacterial activity in vitro and in vivo is stronger than that of oxytetracycline and tetracycline. It is mainly used for the treatment of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/65A61P31/04
CPCA61K9/2054A61K9/0056A61K9/2018A61K31/65
Inventor 鞠伯艳
Owner TIANJIN HENGSHENG GAOKE BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products